Safety and Efficacy of Limited Laboratory Monitoring for Hepatitis C Treatment: A Blinded Clinical Trial in Rwanda

Direct‐acting antivirals for hepatitis C virus (HCV) are highly effective and well‐tolerated. However, only a small percentage of HCV‐infected individuals globally have received therapy. Reducing the complexity of monitoring during HCV therapy, if shown to be safe, could facilitate greater access to...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Hepatol Commun
Asıl Yazarlar: Grant, Philip, Shumbusho, Fabienne, Van Nuil, Jennifer Ilo, Kateera, Fredrick, Mukherjee, Joia, Kabahizi, Jules, Ntaganda, Fabien, Nsanzimana, Sabin, Mbituyumuremyi, Aimable, Damascene, Makuza Jean, Muvunyi, Claude Mambo, Mukabatsinda, Constance, Musabeyezu, Emmanuel, Ntirenganya, Cyprien, Gupta, Neil
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2020
Konular:
Original Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7109339/
https://ncbi.nlm.nih.gov/pubmed/32258951
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep4.1482
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller